Cardiac transplantation: the Stanford experience in the cyclosporine era.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Thoracic and Cardiovascular Surgery

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 8041172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients.

  1993cited by this paper
• Rejection After Cardiac Transplantation: A Time‐Related Risk Factor Analysis

  1992cited by this paper
• Transplant coronary artery disease: histopathologic correlations with angiographic morphology.

  1991cited by this paper
• Eight-year results of cyclosporine-treated patients with cardiac transplants.

  1990cited by this paper
• Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.

  1990cited by this paper
• Cardiac retransplantation in the cyclosporine era.

  1989cited by this paper
• Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.

  1989cited by this paper
• A PROSPECTIVE COMPARISON OF MURINE MONOCLONAL CD‐3 (OKT3) ANTIBODY‐BASED AND EQUINE ANTITHYMOCYTE GLOBULIN‐BASED REJECTION PROPHYLAXIS IN CARDIAC TRANSPLANTATION

  1989cited by this paper
• Pulmonary vascular resistance and the risk of heart transplantation.

  1988cited by this paper
• Heart transplantation in elderly patients.

  1988cited by this paper
• HLA compatibility and cardiac transplant recipient survival.

  1987cited by this paper
• Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.

  1987cited by this paper
• Cardiac transplantation in patients over 50 years of age.

  1986cited by this paper
• Orthotopic heart and combined heart and lung transplantation with cyclosporin-A immune suppression.

  1981cited by this paper
• Current expectations in cardiac transplantation.

  1978cited by this paper
• Determinants of operative risk in human heart transplantation.

  1971cited by this paper

• Toll-like receptors and damage-associated molecular patterns in the pathogenesis of heart transplant rejection

  2022cites this paper
• Cyclosporine A as a cardioprotective agent during donor heart retrieval, storage or transportation - benefits and limitations.

  2019cites this paper
• Anesthetic management of the patient undergoing heart transplantation.

  2017cites this paper
• Renal function at 1 year after cardiac transplantation rather than acute kidney injury is highly associated with long‐term patient survival and loss of renal function – a retrospective cohort study

  2017cites this paper
• State of the Art of Combined Heart-Lung Transplantation for Advanced Cardiac and Pulmonary Dysfunction

  2016cites this paper
• Clinical outcome and quality of life of patients surviving 20 years or longer after heart transplantation

  2014cites this paper
• A randomized controlled trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation

  2014cites this paper
• Surviving 20 years after heart transplantation: a success story.

  2014cites this paper
• Oxidative capacities of cardiac and skeletal muscles of heart transplant recipients: mitochondrial effects of cyclosporin‐A and its vehicle Cremophor‐EL

  2014cites this paper
• Inhibition of MCP-1/CCR2 Signaling Does Not Inhibit Intimal Proliferation in a Mouse Aortic Transplant Model

  2008cites this paper
• Delayed onset of cardiac allograft vasculopathy by induction therapy using anti-thymocyte globulin.

  2008cites this paper
• Current status of heart assist and replacement in Taiwan.

  2008cites this paper
• Twenty‐Year Survivors of Heart Transplantation at Stanford University

  2008cites this paper
• Immunosuppressive Therapy in Older Cardiac Transplant Patients

  2007cites this paper
• Mitral Valve Reconstruction in the Failing Heart

  2007cites this paper
• Exercise Responses Following Heart Transplantation: 5 Year Follow-Up

  2006cites this paper
• Eighteen years of heart transplantation--a single center experience.

  2006cites this paper
• Induction Therapy for Pediatric and Adult Heart Transplantation: Comparison Between OKT3 and Daclizumab

  2005cites this paper
• A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation.

  2005cites this paper
• Calcineurin inhibitors in heart transplantation.

  2005cites this paper
• Graft vascular disease after cardiac transplantation and its relationship to mean acute rejection score.

  2005cites this paper
• Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience.

  2004cites this paper
• Heart transplantation. A retrospective analysis of the long-term results.

  2004cites this paper
• [Incidence and clinical impact of pulmonary homograft dysfunction after the Ross procedure].

  2004cites this paper
• Donor and recipient-transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease.

  2004cites this paper
• Long-Term Treatment With a Specific Rho-Kinase Inhibitor Suppresses Cardiac Allograft Vasculopathy in Mice

  2004cites this paper
• Cause of death and sudden cardiac death after heart transplantation. An autopsy study.

  2003cites this paper
• Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era.

  2003cites this paper
• Immunologic factors in transplant arteriopathy: insight from animal models.

  2003cites this paper
• Delayed Complete Recovery of Graft Dysfunction After Cardiac Transplantation

  2003cites this paper
• Myocardial preservation using Celsior solution in cardiac transplantation: early results and 5-year follow-up of a multicenter prospective study of 70 cardiac transplantations.

  2002cites this paper
• The impact of diabetes mellitus at the time of heart transplantation on long-term survival

  2002cites this paper
• Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy.

  2001cites this paper
• Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center.

  2001cites this paper
• [Incidence and dynamic behavior of spontaneous echocardiographic contrast and atrial thrombi in the transplanted heart].

  2001cites this paper
• Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine era.

  2001cites this paper
• Late rejection is a predictor of transplant coronary artery disease in children.

  2001cites this paper
• Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines.

  2000cites this paper
• Simvastatin attenuates vascular hypercoagulability in cardiac transplant recipients.

  2000cites this paper
• Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation.

  2000cites this paper
• Immunosuppressive treatment affects cardiac and skeletal muscle mitochondria by the toxic effect of vehicle.

  2000cites this paper
• Pulmonary hypertension in pediatric heart transplantation.

  2000cites this paper
• Gender-dependent differences in outcome after the treatment of infection in hospitalized patients.

  1999cites this paper
• Donor MHC and adhesion molecules in transplant arteriosclerosis.

  1999cites this paper
• Thirty years of cardiac transplantation at Stanford university.

  1999cites this paper
• Lack of influence of gender on outcomes of mechanically ventilated medical ICU patients.

  1999cites this paper
• RISK FACTOR MODIFICATION EXTENDS THE BENEFIT OF CORONARY ARTERY REVASCULARISATION PROCEDURES

  1999cites this paper
• Low incidence of transplant coronary artery disease in Chinese heart recipients.

  1999cites this paper
• Heart transplantation with marginal recipients and donors.

  1999cites this paper
• Induction of immunosuppression with OKT3 following heart transplantation: kidney function as a criterion for control of protocol duration.

  1999cites this paper
• Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria.

  1998cites this paper
• Continuous venovenous hemofiltration and hemodialysis after orthotopic heart transplantation.

  1998cites this paper
• Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry.

  1998cites this paper
• Predictors of early mortality after heart transplantation: the Canadian transplant experience from 1981 to 1992. The CASCADE Investigators. Canadian Study of Cardiac Transplant Atherosclerosis Determinants.

  1998cites this paper
• Cardiac transplantation in Taiwan.

  1998cites this paper
• Immune monitoring in cardiac transplant recipients.

  1997cites this paper
• Patent foramen ovale presenting as refractory hypoxemia after heart transplantation.

  1997cites this paper
• Hypercholesterolemia exacerbates transplant arteriosclerosis via increased neointimal smooth muscle cell accumulation: studies in apolipoprotein E knockout mice.

  1997cites this paper
• HMG-CoA reductase inhibitors reduce transplant coronary artery disease and mortality: evidence for antigen-independent mechanisms?

  1997cites this paper
• The impact of gender on outcome from mechanical ventilation.

  1997cites this paper
• Immunsuppression nach Herz- und Lungentransplantation

  1997cites this paper
• The role of specific genes in transplant arteriosclerosis: studies in mutant mice.

  1997cites this paper
• Cardiac transplantation for endstage heart disease.

  1997cites this paper
• Status of patients presently living 9 to 13 years after orthotopic heart transplantation.

  1997cites this paper
• Cardiomyoplasty as an isolated procedure to treat refractory heart failure.

  1997cites this paper
• Donor-recipient size matching in pediatric heart transplantation: a word of caution about small grafts.

  1996cites this paper
• Heart transplantation for chronic Chagas' heart disease.

  1996cites this paper
• Long-term cardiopulmonary exercise performance after heart transplantation.

  1996cites this paper
• Survival benefits of heart and lung transplantation.

  1996cites this paper
• Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.

  1996cites this paper
• Heart transplantation: a single-center experience.

  1996cites this paper
• [Orthotopic and heterotopic heart transplantation].

  1996cites this paper
• Low doses of inhaled nitric oxide in heart transplant recipients.

  1996cites this paper
• Cardiac Transplantation: a review.

  1996cites this paper
• Induction of tolerance to cardiac allografts.

  1996cites this paper
• Extracorporeal membrane oxygenation before and after heart transplantation.

  1996cites this paper
• Recent advances in cardiac transplantation.

  1995cites this paper
• The incidence of renal failure in one hundred consecutive heart-lung transplant recipients.

  1995cites this paper
• Noninvasive detection of cardiac graft vascular disease.

  1995cites this paper